- €3.41bn
- €3.45bn
- €4.07bn
- 97
- 51
- 26
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,624 | 2,332 | 2,925 | 3,783 | 4,069 |
Cost of Revenue | |||||
Gross Profit | 2,399 | 2,105 | 2,617 | 3,345 | 3,620 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,386 | 2,213 | 2,637 | 3,190 | 3,749 |
Operating Profit | 238 | 119 | 288 | 593 | 320 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 235 | 133 | 286 | 595 | 320 |
Provision for Income Taxes | |||||
Net Income After Taxes | 157 | 96.4 | 208 | 457 | 233 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 164 | 98 | 208 | 458 | 233 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 164 | 98 | 208 | 458 | 233 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.27 | 3.26 | 6.35 | 8.76 | 7.48 |
Dividends per Share |